Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO

Exclusion Criteria

• •1. The researchers believe that there are other causes of active bleeding that are not suitable to participate in this study.
• •2. Long-term use of anticoagulants before establishment of ECMO
• •3. Antiplatelet drugs were used before the establishment of ECMO
• •4. Severe liver insufficiency
• •5. Connective tissue disease
• •6. There is a history of allergy to heparin or nemolastat mesylate.
• •7. Pregnant
• •8. Previous diagnosis of heparin-induced thrombocytopenia
• •9. Expect to die within 48 hours
• •10. ECPR